BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6231399)

  • 1. [Cause for visualization of the liver in bone scintigraphy--the effect of the combined use of iron chondroitin sulfate (Blutal)].
    Tanaka S; Sawa H; Fukuda T; Tanaka M; Tsujita Y; Yahata S; Nakajima H; Taniguchi S; Inoue Y; Omura M
    Kaku Igaku; 1983 Sep; 20(8):1175-81. PubMed ID: 6231399
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic uptake of Tc-99m MDP on bone scintigraphy from intravenous iron therapy (Blutal).
    Park CH; Kim HS; Shin HY; Kim HC
    Clin Nucl Med; 1997 Nov; 22(11):762-4. PubMed ID: 9363385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uptake of 99mTc-MDP by the lung and liver].
    Ohchida T; Ichiya A; Matsuura K; Ooiwa T
    Rinsho Hoshasen; 1984 Mar; 29(3):437-8. PubMed ID: 6235386
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extraosseous nuclide uptake during skeletal scintigraphy. Heparin-calcium-induced 99mTc-HMDP accumulation].
    Baum RP; Brandhorst I; Maul FD; Hör G
    Rofo; 1985 Aug; 143(2):247-9. PubMed ID: 2992051
    [No Abstract]   [Full Text] [Related]  

  • 5. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient accumulation of Tc 99m MDP in the liver.
    Dudczak R; Angelberger P; Kletter K; Frischauf H
    Eur J Nucl Med; 1980 Apr; 5(2):189-91. PubMed ID: 6445828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observation of diffuse renal accumulation of 99mTc-MDP].
    Takeji H; Sui O; Shimazu H; Watanabe N; Kawaguchi K; Kawahara Y; Komatsu Y; Yoshida S
    Rinsho Hoshasen; 1984 Aug; 29(8):875-9. PubMed ID: 6210380
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract]   [Full Text] [Related]  

  • 10. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
    Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
    Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
    Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
    J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusely increased Tc-99m-MDP uptake in both kidneys.
    Koizumi K; Tonami N; Hisada K
    Clin Nucl Med; 1981 Aug; 6(8):362-5. PubMed ID: 6455233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extraosseous accumulation of 99m-Tc-MDP--with special reference to intratumor accumulation].
    Yasuda E; Yoshida H; Ichikawa H; Matsuo S; Kimura T; Kanamori I; Nakano S; Watahiki H; Takeda I
    Rinsho Hoshasen; 1983 Aug; 28(8):851-7. PubMed ID: 6228679
    [No Abstract]   [Full Text] [Related]  

  • 15. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experience with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) as a new bone scanning agent].
    Hayasaka K; Arakawa K; Sugie H; Amoh K
    Radioisotopes; 1984 Oct; 33(10):714-6. PubMed ID: 6522651
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased renal uptake of [99mTc]methylene diphosphonate.
    Lin DS; Sanders JA; Flowers WM
    Int J Nucl Med Biol; 1982; 9(3):201-7. PubMed ID: 6215374
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal accumulation of 99mTc-hydroxymethylene diphosphonate in the gallbladder 5 cases and their clinical study--].
    Bussaka H; Takahashi M
    Kaku Igaku; 1982 Jun; 19(5):817-21. PubMed ID: 7176194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abnormal accumulation of 99mTc-phosphorous compounds in the breast].
    Inoue Y; Shichijo S
    Rinsho Hoshasen; 1983 Aug; 28(8):845-9. PubMed ID: 6317921
    [No Abstract]   [Full Text] [Related]  

  • 20. Visualization of the liver, gallbladder, and intestine on bone scintigraphy.
    Sherkow L; Ryo UY; Fabich D; Patel GC; Pinsky SM
    Clin Nucl Med; 1984 Aug; 9(8):440-3. PubMed ID: 6236927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.